Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.
about
Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusAdvances in the management of Barrett's esophagus and early esophageal adenocarcinomaPredictive biomarkers for Barrett's esophagus: so near and yet so farBOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Endoscopic risk factors for neoplastic progression in patients with Barrett's oesophagusBarrett's oesophagus: frequency and prediction of dysplasia and cancerTreatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes.Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus.Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus.Medical and endoscopic management of high-grade dysplasia in Barrett's esophagusEsophageal diseases.Risk factors and chemoprevention in Barrett's esophagus--an update.Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON ConsortiumStatins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis.Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysisBarrett's oesophagus: epidemiology, cancer risk and implications for management.Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagusMolecular markers and imaging tools to identify malignant potential in Barrett's esophagusScreening for Barrett's esophagus and esophageal adenocarcinoma: rationale, recent progress, challenges, and future directions.Advances in the evaluation and management of esophageal disease of systemic sclerosis.Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition.Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Evidence-based endoscopic management of Barrett's esophagusThe minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinomaPredictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Barrett esophagus and life expectancy: implications for screening?Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux DiseaseVitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.Current status and future perspectives on the etiology of esophageal adenocarcinoma.Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.Esophageal cancer incidence and mortality in China, 2010.Urinary metabolomic signature of esophageal cancer and Barrett's esophagus.Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's EsophagusGERD-Barrett-Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?
P2860
Q24202793-EDC9D13C-35C9-4E93-9D5A-FCD7E3961536Q26781194-68984B6E-4810-4822-B87D-E01E89E2EA9BQ26849403-A1629AF4-BE0B-40B7-AD4E-C649B2B7383EQ27332349-421950BC-EF62-43E3-908E-37E1DC23D139Q28079946-26051686-DE58-442F-B78B-801E3A157981Q28080794-83C7F82F-45B2-42E4-8A99-639D1E7122C8Q30472472-0E382060-7D50-4C2A-A980-0FD31A794F88Q30544316-210FBAA2-505A-4DC6-8D68-544BC8D0896FQ30685917-72F2C345-998E-4CCE-91F3-350C2FEA261FQ33948451-72FAA300-EA5C-4214-A2B4-382511F06893Q34024948-D2C19744-D97D-40C8-9F74-117D26A5D88BQ34050233-1970C333-A76B-40C2-844B-C55F91CA9A9CQ34081205-95492F6C-1474-4F32-8623-B369ECA35CEEQ34201351-5A931412-F22B-4510-90A6-C0AFB491CF2EQ34298428-7499639A-ED48-48D2-A85E-622D80FFBE36Q34307588-A69C7695-6B9A-4EF4-80F4-CD35440DA6D5Q34324864-A463B2D5-7A75-479B-80EB-27959A2A02EAQ34352867-B7BB3FFD-8015-417E-8E8F-849360A690B6Q34375216-1DF1AB83-23B7-48A5-BDC1-6FAAECA5A061Q34429198-BBB810E8-67EC-428A-8459-88388C231B99Q34508850-E4D60E07-AED7-42EA-936D-DFA574D86CDCQ34624586-D4EF5EDD-1CF1-4543-B905-38BF9BE9DE4AQ34666835-396562B5-1272-4626-9144-2AD551411E2DQ34898182-8BE04EE9-7B48-4B8F-B31B-5621DA0928ACQ35013649-182FB33C-0335-4054-9BA6-21D1BBCE4543Q35046884-A200E18E-150F-4564-92E8-8C39CEF8E091Q35074266-25650C99-3D95-49DC-B3D8-F6140ADC1892Q35125620-62A65C5B-F826-4434-AA08-363EA496AA09Q35666515-4AB8B81E-9461-4D9F-8E9E-8CCAF94AC437Q35691419-E240FF09-F542-4E62-A310-5AE8CFF2D05CQ35792782-0C3152E0-CCC2-4E39-8B9C-70511A8B5FEEQ35890113-D1843BAA-0BEA-4A7B-905A-7A23A980751FQ35946806-0F767E4E-F0D6-454A-B2B9-B99BEB9C4E2BQ35972032-FD419A4C-1608-46E3-82AC-C7C4452083A7Q36096019-9ACF8624-FC9E-4DF1-A4B9-587572F40143Q36162518-3AB185AF-948E-4DBB-AD17-5AD4F87FD111Q36439476-497711AF-6725-4650-86EF-203615F6D35FQ36630841-ECC39781-0C8B-410E-927D-ED0D49523295Q36672337-F915FDCB-E686-49F8-B9EA-73AF98D61DB7Q36737638-09F75F5C-1133-4997-AB01-C97D93840954
P2860
Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@en
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@nl
type
label
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@en
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@nl
prefLabel
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@en
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@nl
P921
P1476
Risk of esophageal adenocarcin ...... atic review and meta-analysis.
@en
P2093
Marjolein Sikkema
Pieter J F de Jonge
P304
235-44; quiz e32
P356
10.1016/J.CGH.2009.10.010
P407
P577
2009-10-20T00:00:00Z